Matches in Nanopublications for { ?s ?p "[We conclude that the inactivating mutations and/or allelic loss of the HRPT2 gene may not play a major role in parathyroid carcinogenesis in secondary HPT due to CKD, but in these cases cancer development may be associated with a heterogeneous genetic disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP168965.RAge50x0Wt1U4Srp2MhuPRI8EFsQ7Vbl-7JFpFev3HAvo130_assertion description "[We conclude that the inactivating mutations and/or allelic loss of the HRPT2 gene may not play a major role in parathyroid carcinogenesis in secondary HPT due to CKD, but in these cases cancer development may be associated with a heterogeneous genetic disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP168965.RAge50x0Wt1U4Srp2MhuPRI8EFsQ7Vbl-7JFpFev3HAvo130_provenance.
- NP335998.RAyEr4WwncnbyVBQx2svX2QjfC2M1nZ_zZVsCjAyN48rk130_assertion description "[We conclude that the inactivating mutations and/or allelic loss of the HRPT2 gene may not play a major role in parathyroid carcinogenesis in secondary HPT due to CKD, but in these cases cancer development may be associated with a heterogeneous genetic disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335998.RAyEr4WwncnbyVBQx2svX2QjfC2M1nZ_zZVsCjAyN48rk130_provenance.
- NP943649.RACUnNcPoUYJKg9KqdNc-kvvlA5Uprz0sP-mW4x3FMgvQ130_assertion description "[We conclude that the inactivating mutations and/or allelic loss of the HRPT2 gene may not play a major role in parathyroid carcinogenesis in secondary HPT due to CKD, but in these cases cancer development may be associated with a heterogeneous genetic disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP943649.RACUnNcPoUYJKg9KqdNc-kvvlA5Uprz0sP-mW4x3FMgvQ130_provenance.
- NP902289.RAnp0JX_LfI9PIT1ZPx_7ywSqrfocNYgtlM6FZP5I8du8130_assertion description "[We conclude that the inactivating mutations and/or allelic loss of the HRPT2 gene may not play a major role in parathyroid carcinogenesis in secondary HPT due to CKD, but in these cases cancer development may be associated with a heterogeneous genetic disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902289.RAnp0JX_LfI9PIT1ZPx_7ywSqrfocNYgtlM6FZP5I8du8130_provenance.
- NP943556.RA-qWU4MbL8kA0W78QlhFFMqp3G7MAlEj7_-yd_KMQwG0130_assertion description "[We conclude that the inactivating mutations and/or allelic loss of the HRPT2 gene may not play a major role in parathyroid carcinogenesis in secondary HPT due to CKD, but in these cases cancer development may be associated with a heterogeneous genetic disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP943556.RA-qWU4MbL8kA0W78QlhFFMqp3G7MAlEj7_-yd_KMQwG0130_provenance.
- NP943573.RA72NmijfMPDnW_vKfC_12eAXmwmjTgspBZGtgeMyLkBg130_assertion description "[We conclude that the inactivating mutations and/or allelic loss of the HRPT2 gene may not play a major role in parathyroid carcinogenesis in secondary HPT due to CKD, but in these cases cancer development may be associated with a heterogeneous genetic disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP943573.RA72NmijfMPDnW_vKfC_12eAXmwmjTgspBZGtgeMyLkBg130_provenance.
- NP943672.RA1zc72Rl3proXnktGyUorot21STCltH8YY94nPZTs7BY130_assertion description "[We conclude that the inactivating mutations and/or allelic loss of the HRPT2 gene may not play a major role in parathyroid carcinogenesis in secondary HPT due to CKD, but in these cases cancer development may be associated with a heterogeneous genetic disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP943672.RA1zc72Rl3proXnktGyUorot21STCltH8YY94nPZTs7BY130_provenance.
- NP660403.RA812-LUjRZgbGUjKA7cwjGRDBL46nnEuH1yGiT0PSORs130_assertion description "[We conclude that the inactivating mutations and/or allelic loss of the HRPT2 gene may not play a major role in parathyroid carcinogenesis in secondary HPT due to CKD, but in these cases cancer development may be associated with a heterogeneous genetic disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660403.RA812-LUjRZgbGUjKA7cwjGRDBL46nnEuH1yGiT0PSORs130_provenance.
- assertion description "[We conclude that the inactivating mutations and/or allelic loss of the HRPT2 gene may not play a major role in parathyroid carcinogenesis in secondary HPT due to CKD, but in these cases cancer development may be associated with a heterogeneous genetic disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We conclude that the inactivating mutations and/or allelic loss of the HRPT2 gene may not play a major role in parathyroid carcinogenesis in secondary HPT due to CKD, but in these cases cancer development may be associated with a heterogeneous genetic disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We conclude that the inactivating mutations and/or allelic loss of the HRPT2 gene may not play a major role in parathyroid carcinogenesis in secondary HPT due to CKD, but in these cases cancer development may be associated with a heterogeneous genetic disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP943623.RAh1fBv1-4ncEPItnoYZrARegpiFs3EINfpB1u1zyBDC0130_assertion description "[We conclude that the inactivating mutations and/or allelic loss of the HRPT2 gene may not play a major role in parathyroid carcinogenesis in secondary HPT due to CKD, but in these cases cancer development may be associated with a heterogeneous genetic disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP943623.RAh1fBv1-4ncEPItnoYZrARegpiFs3EINfpB1u1zyBDC0130_provenance.
- NP660404.RAn7Hi9FSU6aNs37haOYAlN5awK30HJxud7NL0eEPNAJI130_assertion description "[We conclude that the inactivating mutations and/or allelic loss of the HRPT2 gene may not play a major role in parathyroid carcinogenesis in secondary HPT due to CKD, but in these cases cancer development may be associated with a heterogeneous genetic disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660404.RAn7Hi9FSU6aNs37haOYAlN5awK30HJxud7NL0eEPNAJI130_provenance.